Your session is about to expire
← Back to Search
Thrombectomy Device
Best medical care for Stroke (Tension Trial)
N/A
Waitlist Available
Led By Martin Bendszus, MD
Research Sponsored by University Hospital Heidelberg
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights
Tension Trial Summary
This trial is testing whether a common treatment for stroke, endovascular thrombectomy, is effective and safe in patients with extended stroke lesions. Up to 665 subjects will be randomized and followed for 90 days.
Eligible Conditions
- Stroke
Tension Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical outcome-modified Rankin Scale at 90 days
Secondary outcome measures
Cost Utility Assessment
Frequencies of Adverse Events (AE) in both treatment arms within the first 7 days
Functional neurological outcome at 12 months - modified Rankin Scale
+13 moreTension Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Best medical careExperimental Treatment1 Intervention
Best medical treatment
Group II: ThrombectomyActive Control1 Intervention
Endovascular thrombectomy and best medical care
Find a Location
Who is running the clinical trial?
University Hospital, MartinOTHER
7 Previous Clinical Trials
5,855 Total Patients Enrolled
2 Trials studying Stroke
275 Patients Enrolled for Stroke
Medical University InnsbruckOTHER
234 Previous Clinical Trials
9,436,944 Total Patients Enrolled
8 Trials studying Stroke
9,589 Patients Enrolled for Stroke
Groupe Hospitalier Pitie-SalpetriereOTHER
100 Previous Clinical Trials
2,013,088 Total Patients Enrolled
1 Trials studying Stroke
66 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a neurological or psychiatric condition that may affect the study's results or make it difficult to evaluate your neurological and functional abilities.You are not expected to live for more than 6 to 12 months.Your ability to perform daily activities was not significantly affected by a recent stroke or neurological condition.You have a condition such as aortic dissection or aneurysm that makes it impossible to use endovascular treatment.You have experienced an ischemic stroke, which means you have symptoms such as difficulty speaking, moving, feeling, thinking, looking, or seeing for at least 30 minutes and have not improved.
Research Study Groups:
This trial has the following groups:- Group 1: Thrombectomy
- Group 2: Best medical care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this research endeavor currently ongoing?
"The clinical trial is actively recruiting, as indicated on the listing posted to clinicaltrials.gov. Initially published in June 2018 and updated lastly in September 2021, this study seeks individuals who are eligible for enrolment."
Answered by AI
What is the scale of this medical experiment, in terms of patients involved?
"Affirmative, the information on clinicaltrials.gov reveals that this trial is actively searching for participants. The investigation was initially posted on June 20th 2018 and updated most recently on September 28 2021. In order to complete the study, 665 patients are required from 1 site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger